Device Trial Radar · NCT03884283
Prospective, Multi-center Study to Assess Posterolateral Fusion Using FIBERGRAFT
Last checked: Nov 20, 2026Latest source record: Apr 22, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
102
Actual
Start
Feb 19, 2019
Primary completion
May 21, 2023
Study completion May 21, 2023
Sponsor
- Lead sponsor
- Prosidyan, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 21, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a prospective, non-randomized (single arm), multi-center, post-market clinical study designed to evaluate FIBERGRAFT® BG Matrix mixed with autograft and bone marrow aspirate in up to 150 subjects with degenerative disc disease (DDD) with or without radiculopathy, or spinal stenosis and/or spondylolisthesis requiring a fusion. The patient population will include adult (skeletally mature) men and women undergoing 1 or 2 level fusion in the lumbar spine (L2-S1) who are deemed eligible for the study, characterized by inclusion and exclusion criteria.
Conditions
- Degenerative Disc Disease
- Spondylolisthesis
- Spinal Stenosis Lumbar
Interventions
FIBERGRAFT BG MatrixDevice
Subjects who meet the criteria for entrance into the study will undergo posterolateral fusion using FIBERGRAFT® BG Matrix in combination with autograft and bone marrow aspirate (BMA)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Spinal fusionTime frame: 12 months
Locations
9 sites in 1 country. Site status is shown where the registry gives one.
Long Beach Medical Center
Long Beach, California
Memorial Orthopaedic Surgical Group
Long Beach, California
Palm Beach Neurosurgery
Wellington, Florida
6 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.